Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

Zhejiang Jiuzhou Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
137,106.60
199,692.10
111,375.10
146,786.70
155,921.70
Depreciation, Depletion & Amortization
-
71,064.60
109,384.10
152,831.90
168,019.20
175,930.50
Other Funds
56,076.20
699,598.90
591,735.00
6,897.00
10,241.20
63,913.20
Funds from Operations
203,861.10
242,726.80
288,429.30
270,294.60
358,883.10
400,670
Changes in Working Capital
-
220,279.00
146,170.30
133,648.10
115,894.80
135,887.50
Net Operating Cash Flow
203,861.10
22,447.70
142,259.00
136,646.40
242,988.30
264,782.50
Capital Expenditures
121,748.60
257,130.70
300,203.70
145,461.40
133,415.70
Sale of Fixed Assets & Businesses
982.50
36,622.30
16,490.30
9,410.80
1,210.60
Purchase/Sale of Investments
10,616.80
99,100.00
342,778.70
436,016.00
-
Net Investing Cash Flow
134,673.00
319,608.40
653,044.30
307,575.90
132,205.10
Cash Dividends Paid - Total
-
35,868.60
41,556.00
66,471.90
44,314.60
Issuance/Reduction of Debt, Net
21,294.90
307,270.90
68,565.70
293,944.40
17,732.60
Net Financing Cash Flow
34,781.30
356,459.40
481,613.40
367,313.30
16,340.80
Net Change in Cash
26,674.40
57,684.40
7,968.80
96,726.30
67,670.60
Free Cash Flow
82,112.50
234,683.00
157,944.70
8,815.00
109,572.60
Deferred Taxes & Investment Tax Credit
-
3,636.90
188.90
1,074.60
232.30
4,904.50
Net Assets from Acquisitions
-
-
26,552.20
-
-
Other Sources
2,351.30
-
-
7,610.50
-
Exchange Rate Effect
7,732.40
1,614.40
21,203.20
19,817.20
26,771.70
Other Uses
26,875.00
-
-
-
-

About Zhejiang Jiuzhou Pharmaceutical Co.

View Profile
Address
99 Waisha Road
Taizhou Zhejiang 318000
China
Employees -
Website http://www.jiuzhoupharma.com
Updated 07/08/2019
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. Its products include Carbamazepine, Oxcarbazepine, Duloxetine, Amprolium, Sulphadimethoxine, Sulphadimethoxine Sodium, Sulfasalazine, Bezafibrate, Ketoprofen, Gliclazide, Imipenem, Meropenem, Duloxetine and Pregabalin. The company was founded by Xuan De Hua in 1973 and is headquartered in Taizhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.